Kartik Subramanian
About Kartik Subramanian
Kartik Subramanian is a Senior Principal Scientist at Bristol Myers Squibb, specializing in cancer resistance mechanisms and leveraging high throughput datasets.
Current Position at Bristol Myers Squibb
Kartik Subramanian serves as a Senior Principal Scientist at Bristol Myers Squibb. In this role, he leverages high throughput and multi-dimensional datasets such as CRISPR, transcriptomics, and proteomics to identify biomarkers of resistance to targeted therapy. He collaborates closely with bench scientists in Early target discovery programs, particularly within the Mechanisms of Cancer Resistance (MoCR) Research centre.
Career at Bristol Myers Squibb
Kartik Subramanian has held several positions at Bristol Myers Squibb, including Principal Scientist from 2020 to 2022, and Senior Research Investigator from 2019 to 2020. His progression within the company highlights a strong track record of expertise and contribution to various cutting-edge research projects. His work focuses on the development and application of computational tools and methods for understanding cancer resistance mechanisms.
Academic and Research Positions
Before joining Bristol Myers Squibb, Kartik Subramanian was a Research Associate in Therapeutic Science at Harvard Medical School from 2017 to 2019. He also worked there as a Postdoctoral Fellow from 2015 to 2017. Prior to this, he served as a Graduate Research Assistant at Virginia Tech from 2009 to 2014, where he honed his skills in computational biology. He began his research career as a Project Assistant at the National Chemical Laboratory from 2008 to 2009.
Educational Background
Kartik Subramanian holds a Doctor of Philosophy (Ph.D.) in Computational Biology from Virginia Tech, completed in 2014. He also earned a Future Professoriate Graduate Certificate from the same institution. He has a Master of Science (M.Sc.) in Microbiology from The Maharaja Sayajirao University of Baroda, and a Bachelor of Science (B.Sc.) in Biochemistry from Mumbai University. Additionally, he has studied at UC Irvine.
Research and Development Contributions
During his tenure at Harvard Medical School, Kartik Subramanian applied his expertise in data science, cancer biology, pharmacology, and dynamical modeling at the Laboratory of Systems Pharmacology. He developed and implemented computational tools to understand resistance mechanisms to targeted cancer therapy, contributing significantly to the field of therapeutic science and emerging sequencing technologies.